Meta Biomed Co. Ltd (059210) - Total Liabilities

Latest as of September 2025: ₩58.87 Billion KRW ≈ $39.90 Million USD

Based on the latest financial reports, Meta Biomed Co. Ltd (059210) has total liabilities worth ₩58.87 Billion KRW (≈ $39.90 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 059210 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Meta Biomed Co. Ltd - Total Liabilities Trend (2011–2024)

This chart illustrates how Meta Biomed Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Meta Biomed Co. Ltd assets under control.

Meta Biomed Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Meta Biomed Co. Ltd ranked by their total liabilities.

Company Country Total Liabilities
Jinhui Shipping and Transportation Limited
F:J4O
Germany €169.47 Million
ZEN Graphene Solutions Ltd
NASDAQ:ZTEK
USA $5.18 Million
Infas Holding AG
F:IFS
Germany €59.20 Million
Pinar Su Sanayi ve Ticaret AS
IS:PINSU
Turkey TL1.52 Billion
Cimbeton Hazirbeton ve Prefabrik Yapi Elemanlari Sanayi ve Ticaret AS
IS:CMBTN
Turkey TL1.98 Billion
Pratama Widya Tbk Pt
JK:PTPW
Indonesia Rp99.33 Billion
MGB Bhd
KLSE:7595
Malaysia RM525.43 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Meta Biomed Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Meta Biomed Co. Ltd net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.55 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.49 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.33 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Meta Biomed Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Meta Biomed Co. Ltd (2011–2024)

The table below shows the annual total liabilities of Meta Biomed Co. Ltd from 2011 to 2024.

Year Total Liabilities Change
2024-12-31 ₩83.96 Billion
≈ $56.90 Million
+46.11%
2023-12-31 ₩57.46 Billion
≈ $38.94 Million
-4.99%
2022-12-31 ₩60.48 Billion
≈ $40.99 Million
+34.99%
2021-12-31 ₩44.80 Billion
≈ $30.36 Million
-25.17%
2020-12-31 ₩59.88 Billion
≈ $40.58 Million
+19.70%
2019-12-31 ₩50.02 Billion
≈ $33.90 Million
+4.82%
2018-12-31 ₩47.72 Billion
≈ $32.34 Million
-35.21%
2017-12-31 ₩73.65 Billion
≈ $49.91 Million
+7.54%
2016-12-31 ₩68.49 Billion
≈ $46.41 Million
+8.86%
2015-12-31 ₩62.91 Billion
≈ $42.64 Million
-11.21%
2014-12-31 ₩70.85 Billion
≈ $48.02 Million
-1.93%
2013-12-31 ₩72.25 Billion
≈ $48.96 Million
+15.52%
2012-12-31 ₩62.54 Billion
≈ $42.39 Million
+321.41%
2011-12-31 ₩14.84 Billion
≈ $10.06 Million
--

About Meta Biomed Co. Ltd

KQ:059210 Korea Healthcare Equipment & Supplies
Market Cap
$60.26 Million
₩88.92 Billion KRW
Market Cap Rank
#21289 Global
#1232 in Korea
Share Price
₩3785.00
Change (1 day)
+0.80%
52-Week Range
₩3385.00 - ₩6390.00
All Time High
₩6954.44
About

Meta Biomed Co., Ltd. engages in the research and development, production, and marketing of dental and surgical materials in South Korea and internationally. The company's dental products include endodontics, endodontic materials, restorative materials, and bone graft materials. It also offers suture products comprising multifilament and monofilament products, as well as orthopedics; bone product… Read more